| abstract |
An oral capsule formulation for the controlled release of a 25-hydroxyvitamin D compound in the digestive tract of a subject ingesting the formulation, the formulation comprising a semi-solid solid waxy mixture disposed in a capsule shell, the mixture comprising a compound of 25 -hydroxyvitamin D, a controlled release waxy support, a lipoid agent and an oleaginous vehicle for the compound of 25-hydroxyvitamin D. |